Charles River Laboratories is a pharmaceutical company focusing on drug discovery, development acceleration, and research models. The company provides solutions that streamline the drug development process, including research models and associated services, as well as outsourced preclinical services. Charles River Laboratories operates in two primary segments: Research Models and Services (RMS) and Preclinical Services (PCS), which includes Phase I clinical services. The RMS segment comprises research models, research model services, and other related products.
Founded in 1947, the company is led by CEO James C. Foster and is headquartered in Massachusetts. With 18,400 employees and an annual revenue of $4.0 billion, Charles River Laboratories is an industry leader It supplies research models to the drug development industry, with approximately 150 different strains of genetically and virally defined purpose-bred rats and mice. The company's diverse workforce is 58.4% female and 38.3% ethnic minorities, with a strong Democratic Party affiliation among its employees. Charles River Laboratories has a reputation for employee retention, with staff members typically remaining with the company for 4.9 years and earning an average salary of $45,905 per year.
